Consensus views of the Pharmaceutical Market Support Group and the UK Clinical Pharmacists Association: Neurosciences Group on the safety and appropriateness of switching between brand and generic formulations of anti-epileptic drugs in patients with epilepsy.

Attachments

Print this page

admin